丙型肝炎疫苗相关研究进展
被引量：1
Progress in the research of HCV vaccine
出处
《肝脏》
2004年第4期258-260,共3页
Chinese Hepatology
基金
国家高技术研究发展计划 (863计划 )资助 (2 0 0 2AA2 1 4 1 61 )
参考文献17
-
1Fournillier A, Depla E, Karayiannis P, et al. Expression of noncovalent hepatitis C virus envelope E2-E2 complexes is not required for induction of antibodies with neutralizing properties following DNA immunization. J Virol, 1999,73: 7497-7504. 被引量：1
-
2Horiike N, Akbar SMF, Ninomiya T, et al. Activation and maturation of antigen-presenting dendritic cells during vaccine therapy in patients with chronic hepatitis due to hepatitis B virus. Hepatol Res,2002,23: 38-47. 被引量：1
-
3Rollier C, Depla E, Drexhage JA, et al. Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response. J Virol, 2004,78:187-196. 被引量：1
-
4Domenico R, Susanna C, Carlo M, et al. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycopretein 2 binging to target cells. PNAS USA, 1996,93: 1759-1763. 被引量：1
-
5Esumi M, Rikihisa T, Nishimura S, et al. Experimental vaccine activities of recombinant E1 and E2 glycoproteins and hypervariable region 1 peptides of hepatitis C virus in chimpanzees. Arch Virol, 1999,144: 973-980. 被引量：1
-
6Francois F, Combet C, Germanidis G, et al. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment. J Virol, 2001,75: 5703-5710. 被引量：1
-
7Watanabe K, Yoshioka K, Ito H, et al. The hypervariable region 1protein of hepatitis C virus broadly reactive with sera of patients with chronic hepatitis C has a similar amino acid sequence with the consensus sequence. Virology, 1999,264: 153-158. 被引量：1
-
8Isaguliants MG, Widell A, Zhang SM, et al. Antibody responses against B-cell epitopes of the hypervariable region 1 of hepatitis C virus in self-limiting and chronic human hepatitis C followed-up using consensus peptides. J Med Virol, 2002,66: 204-217. 被引量：1
-
9Zucchelli S, Roccasecca R, Meola A, et al. Mimotopes of the hepatitis C virus hypervariable region 1, but not the natural sequences, induce cross-reactive antibody response by genetic immunization. Hepatology,2001, 33: 692-703. 被引量：1
-
10Farci P, Alter HJ, Wong DC, et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. PNAS USA, 1994,91: 7792-7796. 被引量：1
同被引文献14
-
1鈴木健介,白辑五.丙型肝炎病毒分子机制在临床的应用[J].日本医学介绍,2004,25(8):351-353. 被引量：1
-
2楚莉辉,李琦涵.丙型肝炎DNA疫苗研究进展[J].国外医学（病毒学分册）,2004,11(5):141-145. 被引量：4
-
3王雷,扈荣良.丙型肝炎病毒感染动物模型研究进展[J].中国生物制品学杂志,2007,20(8):617-619. 被引量：4
-
4Pilerip,Oematsuy,campagnolis,et al.Binding of hepatitis Cvirus to CD81. Science . 1998 被引量：1
-
5Farci P,Shimoda A,coiana A,Dia I G,Peddis G,MelpolderJC.The outcome of actue hepatitis predicated by the evolutionof the viral quasispecies. Science . 2007 被引量：1
-
6Liberman E,Fong YL,Sebly M J,et al.Activastion of the gvp78 and pvp 94 promoters by hepatitis C virus E2 evelopeprotein. Journal of Virology . 2005 被引量：1
-
7Kawamura T,Furusaka A,Koziel M J,et al.Transgenic expre-ssion of hepatitis C virus structural proteins in the mouse. Hepatology . 2007 被引量：1
-
8Brazzoli,M,Helenius,A,Foung,SKH,Houghton,M,Abrignani,S,Merola,M.Folding and dimerization of hepatitis C virus E1 and E2 glycoproteins in stably transfected CHO cells. Journal of Virology . 2005 被引量：1
-
9Hideki Nakajima Laurence Cocquerel Nobutaka Kiyokawa Junichiro Fujimoto and Shoshana Levy.Kinetics of HCV envelope proteins’ interaction with CD81 large extracellular loop. Biochemical and Biophysical Research Communications . 2005 被引量：1
-
10徐斌,谢志春.丙型肝炎感染的实验模型研究进展[J].华南预防医学,2008,34(4):53-56. 被引量：1
-
1HarrisonTJ,舒浩麒.丙型肝炎疫苗的展望[J].国外医学（预防．诊断．治疗用生物制品分册）,1995,18(4):153-153.
-
2Howa.,CR,黄惟中.丙型肝炎疫苗的前景[J].国外学者来访报告,1991,11(4):3-4.
-
3GlobeImmune公司丙型肝炎疫苗给慢性丙型肝炎患者带来希望[J].国际生物制品学杂志,2009(3):158-158.
-
4熊秋霞,褚嘉祜.丙型肝炎疫苗研究进展[J].中华传染病杂志,2008,26(5):316-320.
-
5张立营,高博.丙型肝炎疫苗的研究现状[J].热带医学杂志,2011,11(3):358-360. 被引量：10
-
6张庶民.HCV的实验室诊断及疫苗研究进展[J].国外医学（流行病学．传染病学分册）,1999,26(2):55-58. 被引量：4
-
7唐时幸.丙型肝炎疫苗研究进展与展望[J].国外医学（预防．诊断．治疗用生物制品分册）,1994,17(4):148-151.
-
8苏海滨,李跃旗,许鹏辉,迟淑萍,朱雷,戚扬,李金波,程云.慢性HCV感染患者RNA、ALT、AST水平以及细胞因子之间的关系[J].中国医药导刊,2007,9(1):59-60. 被引量：2
-
9张薇（编译）.大鼠肿瘤模型中显示树突细胞型丙型肝炎疫苗有效[J].传染病网络动态,2006(6):11-11.
-
10凌世淦,马贤凯.丙型肝炎疫苗研究进展[J].国外医学（病毒学分册）,1999,6(2):53-54. 被引量：2
